国际医学
(000516)
| 流通市值：92.16亿 | | | 总市值：93.59亿 |
| 流通股本：22.05亿 | | | 总股本：22.39亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 235,968,143.39 | 375,229,992.66 | 411,435,027.78 | 331,072,769.68 |
| 交易性金融资产 | 9,177,246 | 11,096,670 | 12,916,124 | 13,795,860 |
| 应收票据及应收账款 | 501,070,402.38 | 455,523,010.89 | 518,618,735.33 | 616,881,093.77 |
| 应收账款 | 501,070,402.38 | 455,523,010.89 | 518,618,735.33 | 616,881,093.77 |
| 预付款项 | 15,003,580.99 | 15,180,206.08 | 14,471,712.15 | 19,114,837.65 |
| 其他应收款合计 | 22,339,811.29 | 24,096,449.9 | 18,047,454.3 | 49,289,410.59 |
| 存货 | 61,722,540.56 | 58,681,866.73 | 67,228,916.46 | 75,274,149 |
| 合同资产 | 17,946,162.62 | 58,349,619.83 | 45,564,423.05 | - |
| 其他流动资产 | 40,687,452.82 | 43,731,455.9 | 43,124,314.1 | 45,439,576.11 |
| 流动资产合计 | 903,915,340.05 | 1,041,889,271.99 | 1,131,406,707.17 | 1,150,867,696.8 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,271,431.69 | 1,581,474.13 | 1,982,043.37 | 1,513,962.51 |
| 其他非流动金融资产 | 243,679,537.81 | 246,382,113.29 | 246,605,482.66 | 245,822,813.43 |
| 投资性房地产 | 14,910,527.37 | 15,158,637.87 | 15,406,748.37 | 15,654,858.87 |
| 固定资产 | 7,131,224,915.55 | 7,281,199,736.41 | 6,701,045,620.17 | 6,838,102,473.27 |
| 在建工程 | 93,931,745.29 | 92,771,967.79 | 737,294,480.54 | 344,317,451.56 |
| 无形资产 | 669,280,883.6 | 674,776,769.05 | 680,052,931.43 | 684,750,146.68 |
| 长期待摊费用 | 31,780,504.24 | 35,459,131.83 | 39,365,224.87 | 44,585,004.84 |
| 递延所得税资产 | 66,752,952.41 | 66,808,214.72 | 66,878,771.83 | 71,976,312.29 |
| 其他非流动资产 | 31,933,566.83 | 41,413,405.75 | 91,015,373.79 | 393,065,792.64 |
| 非流动资产合计 | 8,284,766,064.79 | 8,455,551,450.84 | 8,579,646,677.03 | 8,639,788,816.09 |
| 资产总计 | 9,188,681,404.84 | 9,497,440,722.83 | 9,711,053,384.2 | 9,790,656,512.89 |
| 流动负债: | | | | |
| 短期借款 | 1,118,436,993.59 | 1,105,699,468.76 | 1,038,863,091.09 | 994,775,888.9 |
| 应付票据及应付账款 | 1,610,665,496.69 | 1,733,285,592.65 | 1,734,047,776.06 | 1,696,993,740.4 |
| 其中：应付票据 | 79,200,000 | 32,400,000 | 22,300,000 | 46,000,000 |
| 应付账款 | 1,531,465,496.69 | 1,700,885,592.65 | 1,711,747,776.06 | 1,650,993,740.4 |
| 预收款项 | 350,494 | 523,023.13 | 410,069.25 | 190,207.71 |
| 合同负债 | 248,894,131.68 | 241,099,096.79 | 238,285,859.96 | 230,420,758.31 |
| 应付职工薪酬 | 131,613,588.28 | 125,752,879.99 | 182,720,613.45 | 165,579,602.55 |
| 应交税费 | 26,091,994.27 | 21,083,238.4 | 23,523,181.64 | 23,718,782.18 |
| 其他应付款合计 | 130,833,331.79 | 140,690,714.85 | 218,207,164.58 | 212,841,791.75 |
| 应付股利 | 1,209,363.18 | 1,209,363.18 | 1,209,363.18 | 1,209,363.18 |
| 一年内到期的非流动负债 | 811,479,711.7 | 848,893,912.78 | 1,016,560,714.49 | 905,070,397.04 |
| 其他流动负债 | 5,068.25 | 5,444.39 | 5,019.58 | 5,137.18 |
| 流动负债合计 | 4,078,370,810.25 | 4,217,033,371.74 | 4,452,623,490.1 | 4,229,596,306.02 |
| 非流动负债: | | | | |
| 长期借款 | 1,939,131,494.83 | 2,120,791,815.73 | 2,168,680,149.04 | 2,493,642,911.24 |
| 长期应付款 | 261,294,203.33 | 209,090,704.18 | 67,256,762.48 | 99,597 |
| 预计负债 | 10,979,633.96 | 9,206,367.27 | 7,413,338.39 | 5,702,185.66 |
| 递延收益 | 5,281,906.39 | 5,002,129.47 | 5,091,429.85 | 4,945,171.12 |
| 递延所得税负债 | 2,715,896.55 | 2,715,896.55 | 2,715,896.55 | 2,400,000 |
| 非流动负债合计 | 2,219,403,135.06 | 2,346,806,913.2 | 2,251,157,576.31 | 2,506,789,865.02 |
| 负债合计 | 6,297,773,945.31 | 6,563,840,284.94 | 6,703,781,066.41 | 6,736,386,171.04 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,238,896,753 | 2,238,896,753 | 2,238,896,753 | 2,238,896,753 |
| 资本公积 | 971,666,482.14 | 971,666,482.14 | 971,666,482.14 | 971,666,482.14 |
| 盈余公积 | 400,702,384.75 | 400,702,384.75 | 400,702,384.75 | 400,702,384.75 |
| 未分配利润 | -358,424,085.39 | -341,445,393.03 | -293,103,843.55 | -273,684,991.31 |
| 归属于母公司股东权益合计 | 3,252,841,534.5 | 3,269,820,226.86 | 3,318,161,776.34 | 3,337,580,628.58 |
| 少数股东权益 | -361,934,074.97 | -336,219,788.97 | -310,889,458.55 | -283,310,286.73 |
| 股东权益合计 | 2,890,907,459.53 | 2,933,600,437.89 | 3,007,272,317.79 | 3,054,270,341.85 |
| 负债和股东权益合计 | 9,188,681,404.84 | 9,497,440,722.83 | 9,711,053,384.2 | 9,790,656,512.89 |
| 公告日期 | 2026-08-21 | 2026-04-24 | 2026-04-24 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |